PHAT logo

Phathom Pharmaceuticals, Inc. (PHAT) Operating profit

annual operating profit:

-$277.47M-$110.16M(-65.84%)
December 31, 2024

Summary

  • As of today (September 16, 2025), PHAT annual operating income is -$277.47 million, with the most recent change of -$110.16 million (-65.84%) on December 31, 2024.
  • During the last 3 years, PHAT annual operating profit has fallen by -$142.39 million (-105.41%).
  • PHAT annual operating profit is now -22550.37% below its all-time high of -$1.23 million, reached on December 31, 2018.

Performance

PHAT Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPHATincome statement metrics

quarterly operating profit:

-$59.92M+$18.94M(+24.02%)
June 30, 2025

Summary

  • As of today (September 16, 2025), PHAT quarterly operating income is -$59.92 million, with the most recent change of +$18.94 million (+24.02%) on June 30, 2025.
  • Over the past year, PHAT quarterly operating profit has increased by +$17.38 million (+22.48%).
  • PHAT quarterly operating profit is now -22259.70% below its all-time high of -$268.00 thousand, reached on September 30, 2018.

Performance

PHAT quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPHATincome statement metrics

TTM operating profit:

-$269.00M+$17.38M(+6.07%)
June 30, 2025

Summary

  • As of today (September 16, 2025), PHAT TTM operating income is -$269.00 million, with the most recent change of +$17.38 million (+6.07%) on June 30, 2025.
  • Over the past year, PHAT TTM operating profit has dropped by -$16.21 million (-6.41%).
  • PHAT TTM operating profit is now -100273.13% below its all-time high of -$268.00 thousand, reached on September 30, 2018.

Performance

PHAT TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPHATincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

PHAT Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-65.8%+22.5%-6.4%
3 y3 years-105.4%-32.1%-80.0%
5 y5 years-161.2%-199.3%-331.3%

PHAT Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-105.4%at low-99.2%+24.0%-86.7%+6.6%
5 y5-year-161.2%at low-199.3%+24.0%-331.3%+6.6%
alltimeall time<-9999.0%at low<-9999.0%+27.8%<-9999.0%+6.6%

PHAT Operating profit History

DateAnnualQuarterlyTTM
Jun 2025
-
-$59.92M(-24.0%)
-$269.00M(-6.1%)
Mar 2025
-
-$78.86M(+32.7%)
-$286.38M(+3.2%)
Dec 2024
-$277.47M(+65.8%)
-$59.42M(-16.1%)
-$277.47M(-3.6%)
Sep 2024
-
-$70.80M(-8.4%)
-$287.93M(+13.9%)
Jun 2024
-
-$77.30M(+10.5%)
-$252.79M(+22.0%)
Mar 2024
-
-$69.95M(+0.1%)
-$207.19M(+23.8%)
Dec 2023
-$167.31M(-3.0%)
-$69.88M(+96.0%)
-$167.31M(+16.1%)
Sep 2023
-
-$35.66M(+12.5%)
-$144.08M(-4.6%)
Jun 2023
-
-$31.70M(+5.4%)
-$150.95M(-8.3%)
Mar 2023
-
-$30.08M(-35.5%)
-$164.61M(-4.5%)
Dec 2022
-$172.44M
-$46.64M(+9.7%)
-$172.44M(+8.6%)
Sep 2022
-
-$42.53M(-6.2%)
-$158.84M(+6.3%)
Jun 2022
-
-$45.36M(+19.7%)
-$149.45M(+7.2%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$37.91M(+14.7%)
-$139.40M(+3.2%)
Dec 2021
-$135.08M(+7.5%)
-$33.04M(-0.3%)
-$135.08M(-12.6%)
Sep 2021
-
-$33.14M(-6.2%)
-$154.48M(+0.2%)
Jun 2021
-
-$35.32M(+5.2%)
-$154.17M(+11.0%)
Mar 2021
-
-$33.58M(-36.0%)
-$138.87M(+10.5%)
Dec 2020
-$125.67M(+18.3%)
-$52.44M(+59.7%)
-$125.67M(+41.3%)
Sep 2020
-
-$32.83M(+64.0%)
-$88.92M(+42.6%)
Jun 2020
-
-$20.02M(-1.7%)
-$62.37M(-50.2%)
Mar 2020
-
-$20.38M(+29.8%)
-$125.36M(+19.4%)
Dec 2019
-$106.22M(+8570.6%)
-$15.69M(+149.8%)
-$104.99M(+17.0%)
Sep 2019
-
-$6.28M(-92.4%)
-$89.75M(+7.2%)
Jun 2019
-
-$83.01M(>+9900.0%)
-$83.73M(>+9900.0%)
Dec 2018
-$1.23M
-$451.00K(+68.3%)
-$719.00K(+168.3%)
Sep 2018
-
-$268.00K
-$268.00K

FAQ

  • What is Phathom Pharmaceuticals, Inc. annual operating income?
  • What is the all time high annual operating profit for Phathom Pharmaceuticals, Inc.?
  • What is Phathom Pharmaceuticals, Inc. annual operating profit year-on-year change?
  • What is Phathom Pharmaceuticals, Inc. quarterly operating income?
  • What is the all time high quarterly operating profit for Phathom Pharmaceuticals, Inc.?
  • What is Phathom Pharmaceuticals, Inc. quarterly operating profit year-on-year change?
  • What is Phathom Pharmaceuticals, Inc. TTM operating income?
  • What is the all time high TTM operating profit for Phathom Pharmaceuticals, Inc.?
  • What is Phathom Pharmaceuticals, Inc. TTM operating profit year-on-year change?

What is Phathom Pharmaceuticals, Inc. annual operating income?

The current annual operating profit of PHAT is -$277.47M

What is the all time high annual operating profit for Phathom Pharmaceuticals, Inc.?

Phathom Pharmaceuticals, Inc. all-time high annual operating income is -$1.23M

What is Phathom Pharmaceuticals, Inc. annual operating profit year-on-year change?

Over the past year, PHAT annual operating income has changed by -$110.16M (-65.84%)

What is Phathom Pharmaceuticals, Inc. quarterly operating income?

The current quarterly operating profit of PHAT is -$59.92M

What is the all time high quarterly operating profit for Phathom Pharmaceuticals, Inc.?

Phathom Pharmaceuticals, Inc. all-time high quarterly operating income is -$268.00K

What is Phathom Pharmaceuticals, Inc. quarterly operating profit year-on-year change?

Over the past year, PHAT quarterly operating income has changed by +$17.38M (+22.48%)

What is Phathom Pharmaceuticals, Inc. TTM operating income?

The current TTM operating profit of PHAT is -$269.00M

What is the all time high TTM operating profit for Phathom Pharmaceuticals, Inc.?

Phathom Pharmaceuticals, Inc. all-time high TTM operating income is -$268.00K

What is Phathom Pharmaceuticals, Inc. TTM operating profit year-on-year change?

Over the past year, PHAT TTM operating income has changed by -$16.21M (-6.41%)
On this page